Sherri Dudal

1.3k total citations
25 papers, 618 citations indexed

About

Sherri Dudal is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sherri Dudal has authored 25 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Molecular Biology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sherri Dudal's work include Biosimilars and Bioanalytical Methods (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Advanced Biosensing Techniques and Applications (5 papers). Sherri Dudal is often cited by papers focused on Biosimilars and Bioanalytical Methods (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Advanced Biosensing Techniques and Applications (5 papers). Sherri Dudal collaborates with scholars based in Switzerland, France and United Kingdom. Sherri Dudal's co-authors include Virginie Lafont, Julie Paquette, Patrick Tremblay, Pascale Krzywkowski, Francine Gervais, Céline Morissette, Diane Lacombe, Antoine Gross, Jacques Dornand and Françoise Sanchez and has published in prestigious journals such as Neuron, The Journal of Immunology and Human Molecular Genetics.

In The Last Decade

Sherri Dudal

24 papers receiving 602 citations

Peers

Countries citing papers authored by Sherri Dudal

Since Specialization

Citations

This map shows the geographic impact of Sherri Dudal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherri Dudal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherri Dudal more than expected).

Fields of papers citing papers by Sherri Dudal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherri Dudal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherri Dudal. The network helps show where Sherri Dudal may publish in the future.

Co-authorship network of co-authors of Sherri Dudal

This figure shows the co-authorship network connecting the top 25 collaborators of Sherri Dudal. A scholar is included among the top collaborators of Sherri Dudal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherri Dudal. Sherri Dudal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The “five-star matrix” for patient-centric drug discovery and development in neuroscience 2025 ·Neuron ·Axel Pähler, Eoin C. O’Connor, (unknown), Sherri Dudal, Luca Gobbi, Thomas Lübbers, Andrés Olivares‐Morales, (unknown), Uwe Grether, Martin Ståhl, Gennaro Pagano, Antonia F. Stepan	0
2	Current nonclinical approaches for immune assessments of immuno-oncology biotherapeutics 2022 ·Drug Discovery Today ·Christine Grimaldi, (unknown), Andrea Kießling, Benno Rattel, Changhua Ji, Claudette L. Fuller, Frank R. Brennan, (unknown), Jacintha Shenton, Karen Price, (unknown), Meredith A. Steeves, Rodney A. Prell, Sherri Dudal, Sven Kronenberg, Wendy Freebern, Diann Blanset	3
3	Translating pharmacology models effectively to predict therapeutic benefit 2022 ·Drug Discovery Today ·Sherri Dudal, Caterina Bissantz, Antonello Caruso, Pascale David‐Pierson, Wouter H. P. Driessen, (unknown), Ben‐Fillippo Krippendorff, Martin Lechmann, Andrés Olivares‐Morales, (unknown), Caroline Rynn, Dietrich Türck, (unknown), Ken Wang, (unknown)	8
4	Review of the Technical, Toxicological, and PKPD Considerations for Conducting Inhalation Toxicity Studies on Biologic Pharmaceuticals—The Outcome of a Cross-Industry Working Group Survey 2021 ·Toxicologic Pathology ·Alison Wolfreys, (unknown), (unknown), Sherri Dudal, (unknown), David Jones, (unknown), Carsten Krantz, (unknown), (unknown), Mark Price, Jeffrey S. Tepper, Annick Cauvin, (unknown), Ian Robinson	3
5	Strategies and Recommendations for Using a Data‐Driven and Risk‐Based Approach in the Selection of First‐in‐Human Starting Dose: An International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Assessment 2020 ·Clinical Pharmacology & Therapeutics ·Michael W. Leach, David O. Clarke, Sherri Dudal, Chao Han, Chunze Li, Zheng Yang, Frank R. Brennan, Wendy J. Bailey, Yingxue Chen, Antoine Deslandes, (unknown), Kapil Mayawala, Mark Rogge, Marque D. Todd, Nagendra Chemuturi	17
6	Real‐World Data and Physiologically‐Based Mechanistic Models for Precision Medicine 2020 ·Clinical Pharmacology & Therapeutics ·Ken Wang, Neil Parrott, Andrés Olivares‐Morales, Sherri Dudal, Thomas P. Singer, Thierry Lavé, Benjamin Ribba	2
7	Model‐Informed Artificial Intelligence: Reinforcement Learning for Precision Dosing 2020 ·Clinical Pharmacology & Therapeutics ·Benjamin Ribba, Sherri Dudal, Thierry Lavé, Richard Peck	42
8	Case Studies Discussing the Pathology, Immunogenicity, and Proposed Mechanism of Toxicity of an Inhaled Anti-TGFβ Humanized Fab Antibody in Non-Human Primates and Mice 2020 ·Toxicologic Pathology ·(unknown), Annick Cauvin, Sherri Dudal, James T. Raymond, Petrina Rogerson, Jacquelin Jolette	1
9	Towardin vitro-to-in vivotranslation of monoclonal antibody pharmacokinetics: Application of a neonatal Fc receptor-mediated transcytosis assay to understand the interplaying clearance mechanisms 2017 ·mAbs ·(unknown), Sara Belli, (unknown), Sherri Dudal, (unknown), Markus Haak, (unknown), Michael B. Otteneder, Mohammed Ullah, Christoph Funk, Franz Schuler, (unknown)	18
10	Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys 2015 ·mAbs ·Sherri Dudal, (unknown), Thierry Flandre, (unknown), Philip J. Lowe, Andrej Skerjanec, (unknown), (unknown), (unknown), A. Cordier, Gábor Járai, Gino Van Heeke, (unknown), Carsten Krantz, (unknown), (unknown), (unknown), (unknown), Peter Lloyd	13
11	Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated Environment 2015 ·The AAPS Journal ·Marian Kelley, Lauren Stevenson, Michaela Golob, Viswanath Devanarayan, João Pedras-Vasconcelos, Roland F. Staack, Rand Jenkins, Brian Booth, Eric Wakshull, Ronald R. Bowsher, (unknown), Sherri Dudal, Binodh DeSilva	2
12	Workshop Report: Crystal City V—Quantitative Bioanalytical Method Validation and Implementation: The 2013 Revised FDA Guidance 2014 ·The AAPS Journal ·Brian Booth, Mark E. Arnold, Binodh DeSilva, Lakshmi Amaravadi, Sherri Dudal, Eric Fluhler, Boris Gorovits, Sam Haidar, John Kadavil, Steve Lowes, Robert I. Nicholson, (unknown), (unknown), Lauren Stevenson, Sriram Subramaniam, Russell Weiner, Eric Woolf	86
13	Use of Generic LC–MS/MS Assays to Characterize Atypical PK Profile of A Biotherapeutic Monoclonal Antibody 2014 ·Bioanalysis ·Wai Siang Law, (unknown), (unknown), (unknown), (unknown), Peter Lloyd, Sherri Dudal, Carsten Krantz	22
14	Assay Formats: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team 2013 ·The AAPS Journal ·Sherri Dudal, Daniel Baltrukonis, (unknown), (unknown), Alison Joyce, (unknown), John Smeraglia, Yoshitaka Taniguchi, Jihong Yang	30
15	Human CD4⁺ invariant NKT cells are involved in antibacterial immunity against Brucella suis through CD1d‐dependent but CD4‐independent mechanisms 2009 ·European Journal of Immunology ·Stéphanie Bessoles, Sherri Dudal, Gurdyal S. Besra, Françoise Sanchez, Virginie Lafont	18
16	Mapping genetic modulators of amyloid plaque deposition in TgCRND8 transgenic mice 2006 ·Human Molecular Genetics ·Giovanna Sebastiani, Pascale Krzywkowski, Sherri Dudal, (unknown), Julie Paquette, Danielle Malo, Francine Gervais, Patrick Tremblay	20
17	Differences in the amyloid-β-induced inflammatory response in microglia from C57BL/6 and A/J strains of mice 2004 ·Journal of Neuroimmunology ·Sherri Dudal, Céline Morissette, Diane Lacombe, Patrick Tremblay, Francine Gervais	4
18	Inflammation occurs early during the Aβ deposition process in TgCRND8 mice 2004 ·Neurobiology of Aging ·Sherri Dudal, Pascale Krzywkowski, Julie Paquette, Céline Morissette, Diane Lacombe, Patrick Tremblay, Francine Gervais	113
19	Cellular bioterrorism: how Brucella corrupts macrophage physiology to promote invasion and proliferation 2004 ·Clinical Immunology ·(unknown), Sherri Dudal, Jacques Dornand, Antoine Gross	62
20	Specific Signaling Pathways Triggered by IL-2 in Human Vγ9Vδ2 T Cells: An Amalgamation of NK and αβ T Cell Signaling 2003 ·The Journal of Immunology ·Virginie Lafont, Séverine Loisel‐Meyer, Janny Liautard, Sherri Dudal, (unknown), Jean‐Pierre Liautard, Jean Favero	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact